Robert J. Bitterman, President & CEO at Phio Pharmaceuticals Corp. (PHIO), bought 2,000 shares at $2.84 ($6K) on 2023-07-01, disclosed to the SEC on 2023-07-05.
Open-market purchase of $6k PHIO by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.88 | 1,000 | $3K | 50.3% |
| 2 | $2.84 | 1,000 | $3K | 49.7% |
| Total | $2.86 avg | 2,000 | $6K | 100% |
| Filing → |
| PHIO | BUY | 2026-01-02 | $5K | — | Filing → |
| PHIO | BUY | 2025-12-29 | $5K | — | Filing → |
| PHIO | BUY | 2025-11-24 | $6K | — | Filing → |